Fierce Pharma
JULY 12, 2024
Trials have already shown that Novo Nordisk’s semaglutide | Trials have already shown that Novo Nordisk’s semaglutide can cut the risk of cardiovascular events and kidney disease. Now a study from the University of Oxford indicates that the company’s semaglutide type 2 diabetes drug Ozempic can reduce the risk of dementia compared with another popular diabetes medicine.
MedCity News
JULY 12, 2024
This week, HHS issued its HTI-2 proposal — a new proposed rule to improve healthcare data sharing among providers, payers, patients and public health organizations. It comes just seven months after HHS issued its HTI-1 rule. The post What’s Included In HHS’ New Interoperability Proposal? appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 12, 2024
Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the future—despite a few promising growth opportunities the team has identified. | Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the drugmaker—despite a few promising growth opportunities they identified.
pharmaphorum
JULY 12, 2024
A new payment policy proposal released by the Centers for Medicare and Medicaid Services (CMS) this week covers digital tools used for behavioural health, which could be a boost for the digital health sector.The Medicare Physician Fee Schedule (PFS) sets out the method of payment, rates, and codes for healthcare providers participating in Medicare, and is often used by the administration as an instrument to encourage some forms of healthcare intervention.
Fierce Pharma
JULY 12, 2024
Even through an onslaught of biosimilar launches that began early last year, AbbVie’s big-selling Humira has been able to retain most of its lucrative market. | With ten biosimilar options in play, AbbVie's star immunology drug lost 13% of its total market share since March, according to a new Samsung Bioepis report.
MedCity News
JULY 12, 2024
The Procurement Maturity Model is more than just a self-assessment tool; it’s an invitation to transform. The post Unlocking Hidden Value: Navigating Healthcare Procurement Maturity appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaVoice
JULY 12, 2024
Patent disputes in the U.S. and abroad have opened the door to new generics ready for launch as soon as September for BMS’ Sprycel.
MedCity News
JULY 12, 2024
Through a new partnership, Cityblock will offer medical and behavioral health services to members with serious mental illness or substance use disorder in Alliance Health’s Behavioral Health and Intellectual/Development Disability Tailored Plan. The post Cityblock, Alliance Health Launch Medicaid Partnership in North Carolina appeared first on MedCity News.
pharmaphorum
JULY 12, 2024
Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category – but has now decided on a lead candidate.The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later this year.
MedCity News
JULY 12, 2024
Like in every other industry, AI is knocking on the doors of healthcare with solutions that promise to revolutionize delivery of care. Advancing from a pen-and-paper mindset to a digital revolution will require the use of bridge technology. The post Cultural Challenges to the Much-Needed Digital Revolution in Healthcare Supply Chain Management appeared first on MedCity News.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
JULY 12, 2024
The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.
MedCity News
JULY 12, 2024
The FDA rejected Novo Nordisk’s biologics license application for icodec, citing questions about the manufacturing process for this once weekly insulin as well as its use by type 1 diabetes patients. But there are several high-profile FDA approvals in our recap of recent regulatory news. The post FDA Says ‘No’ to Novo Nordisk’s Once-Weekly Insulin appeared first on MedCity News.
pharmaphorum
JULY 12, 2024
New UK Health Secretary Wes Streeting orders a 'raw and frank' review of NHS to inform a new 10-year plan to fix it
MedCity News
JULY 12, 2024
The roster of speakers at INVEST Digital Health scheduled for September 18 in Dallas includes executives from health systems, healthcare entrepreneurs, and more. Register today! The post Check Out the Roster of Healthcare Innovators Taking Part in INVEST Digital Health in Dallas appeared first on MedCity News.
Pharmaceutical Technology
JULY 12, 2024
Ipsen has entered an exclusive global licensing agreement with Foreseen Biotech for FS001, a potentially first-in-class ADC.
pharmaphorum
JULY 12, 2024
Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round
PharmaTimes
JULY 12, 2024
The progressive neurodegenerative disease affects more than 55 million people globally
Pharmaceutical Commerce
JULY 12, 2024
The latest news for pharma industry insiders.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaTimes
JULY 12, 2024
The awards celebrated both medical affairs and nursing professionals in the industry
PharmExec
JULY 12, 2024
JAMA study aims to discover how weight loss differs between patients receiving tirzepatide compared with semaglutide among a clinical population of overweight of obese adults.
PharmaTimes
JULY 12, 2024
The serious, rare condition is responsible for up to 7% of all neonatal deaths globally
Contrarian Sales Techniques
JULY 12, 2024
Blood, Sweat, and Samples: A Day in the Life of a GLC Medical Rep The fluorescent lights hummed overhead, casting a sterile glow on the tense faces around the conference table. Dr. Hassan, the notoriously critical head of procurement at General Hospital, was dissecting our proposal like a seasoned surgeon. Sweat beaded on my forehead despite the air-conditioning.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
European Pharmaceutical Review
JULY 12, 2024
A report published by Market Expertz predicts that size of the liquid chromatography reagents market will increase by $3,879.72 million between 2022 and 2032. Demand for high-performance liquid chromatography ( HPLC ) reagents and increasing reliance on chromatography techniques in pharmaceuticals and biotechnology applications are key drivers of the liquid chromatography reagents market, the research asserted.
Contrarian Sales Techniques
JULY 12, 2024
Beyond the Brand Name Dr. Elena Reyes was a doctor's doctor. For over two decades, her patients in the quaint town of Harmony Springs trusted her implicitly. Her spotless record and unwavering commitment to their well-being were legendary. One of the things her patients appreciated most was her reliance on brand-name medications. They felt a sense of security knowing they were getting the "gold standard" in treatment.
Pharmaceutical Technology
JULY 12, 2024
Preclinical biopharmaceutical company Tiba Biotech has announced a partnership with BARDA to develop therapeutics against influenza.
Contrarian Sales Techniques
JULY 12, 2024
Living in the Dragon's Den Being a local med rep for a multinational drug company in Malaysia can feel like living in a dragon's den. Don't get me wrong, MegaPharm is a great company, but sometimes the corporate culture feels about as subtle as a durian fruit. And that's where Brenda "The Barracuda" Benson came in, my sales manager. Brenda was everything a Malaysian wasn't - loud, abrasive, and obsessed with targets.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmaceutical Commerce
JULY 12, 2024
The acquisition in the ophthalmology space features a $1.3 billon cash payment, with the potential for an additional $1.7 billion if various milestones are met.
Pharmaceutical Technology
JULY 12, 2024
The cash injection will accelerate the development of Crossject’s prefilled needle free platform to treat anaphylactic shock.
PharmExec
JULY 12, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JULY 12, 2024
Pan Cancer T has announced a €4.25m ($4.62m) seed extension round to complete of preclinical studies for its leading product, PCT1:CO-STIM.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Expert insights. Personalized for you.
295 
Let's personalize your content